Patients were seen at entry for baseline measurements and assessments and thereafter at months 1, 4, and 7. Baseline assessments included a medical history and a blood sample to assay gonadotrophin concentrations.The number and severity of flushing and sweating episodes (day and night) were documented daily on the diary cards, as well as details of any adverse effects.